Amphastar Pharmaceuticals will release its Q3 2026 financial results on November 5, 2026, after the market close, providing investors with an update on the company's performance for the quarter ending September 30.
Amphastar announced the date for its third quarter 2026 earnings release and conference call, which is a routine scheduling event with no financial impact.
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) has scheduled its third-quarter 2026 financial results release for November 5, 2026. The company will report its performance for the period ending September 30, 2026, following the market close.
Amphastar Pharmaceuticals is scheduled to release its third-quarter 2026 financial results after the market closes on Thursday, November 5, 2026.